Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.7.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.4.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.4.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.65ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.65ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.65ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.65NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.39.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.39.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.39.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.39.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDQ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.4.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.7.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.7.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDK.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.4.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.4.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.8.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.8.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.8.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used